New patent for Amneal drug LYVISPAHBy DrugPatentWatch – Make Better Decisions / April 3, 2024 Annual Drug Patent Expirations for LYVISPAH Lyvispah is a drug marketed by Amneal and is included in one NDA. It is available from two suppliers. There are four patents protecting…Source